Retraction
Anticancer Activity of Metformin, an Antidiabetic Drug, Against Ovarian Cancer Cells Involves Inhibition of Cysteine-Rich 61 (Cyr61)/Akt/Mammalian Target of Rapamycin (mTOR) Signaling Pathway
Paper Information
Record ID:
43022
Author(s):
Journal:
Publication Date:
September 01, 2018
Retraction Date:
March 25, 2021
(4.7 years years ago)
Subjects:
Institutions:
Country:
🇨🇳 ChinaArticle Type:
Publisher:
International Scientific Information, Inc
Open Access:
Yes
DOI:
PubMed ID:
Retraction PubMed ID:
Retraction Details
Retraction Reasons:
Nature of Retraction:
Retraction
Retraction Notice:
10.12659/MSM.932331Additional Notes:
See also: https://pubpeer.com/publications/08813FDA2773E95E4D7D24E00F30DE
Citations (13)
13
Total Citations5
Post-Retraction(38.5%)
7
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
1
Within 30 days
4
Within 1 year
1
After 2+ years
1470
Days since retraction (latest)
Paper citing Anticancer Activity of Metformin, an Antidiabetic ...
Unknown Authors
Unknown Journal
Published: Unknown
Comparative Study of <i>In Vitro</i> Anti-proliferative Activity of Metformin, Teneligliptin, and Canagliflozin Against Breast Cancer Cell Line
Venugopal Gopikrishnan, Punnagai Kumaravelu, S Ramya
Journal of Pharmacology and Pharmacotherapeutics
Published: Apr 2025
1470 days after retraction
A direct bridge to metformin and matrix metalloproteinase relationship in prostate cancer model: oxidative stress
Pınar Köroğlu
Çukurova medical journal (Online)/Çukurova medical journal
Open Access
Published: Mar 2022
348 days after retraction
Effect of metformin use on the risk and prognosis of ovarian cancer: an updated systematic review and meta-analysis
Minzhen Lu, Deyu Li, Xuefeng Wang
Panminerva Medica
Published: Jan 2022
9 citations
9 citations
301 days after retraction
Clinical Implication of Metformin in Relation to Diabetes Mellitus and Ovarian Cancer
Santosh Kumar Singh, Tejumola Apata, Shriti Singh et al. (5 authors)
Biomedicines
Open Access
Published: Aug 2021
9 citations
9 citations
144 days after retraction
The CCN axis in cancer development and progression
Herman Yeger, Bernard Perbal
Journal of Cell Communication and Signaling
Open Access
Published: Apr 2021
21 citations
21 citations
26 days after retraction
Biguanides: Species with versatile therapeutic applications
Deepika Kathuria, Akshay D. Raul, Pravin J. Wanjari et al. (4 authors)
European Journal of Medicinal Chemistry
Published: Mar 2021
56 citations
56 citations
1 days before retraction
Metformin and asarone inhibit HepG2 cell proliferation in a high glucose environment by regulating AMPK and Akt signaling pathway
Bhrigu Kumar Das, Rachel M. Knott, Pramod C. Gadad
Future Journal of Pharmaceutical Sciences
Open Access
Published: Feb 2021
12 citations
12 citations
41 days before retraction
The Role of Metformin in Ovarian Cancer: Does Metformin Increase Survival in Ovarian Neoplasm?
Maimuna F Ahmed, Ghid Kanaan, Jihan A Mostafa
Cureus
Open Access
Published: Feb 2021
10 citations
10 citations
50 days before retraction
Metformin and ovarian cancer: the evidence
Elina Urpilainen, Ulla Puistola, Stergios Boussios et al. (4 authors)
Annals of Translational Medicine
Open Access
Published: Dec 2020
40 citations
40 citations
114 days before retraction
Sitagliptin Modulates the Response of Ovarian Cancer Cells to Chemotherapeutic Agents
Agnieszka Kosowska, Wojciech Garczorz, Agnieszka Kłych‐Ratuszny et al. (7 authors)
International Journal of Molecular Sciences
Open Access
Published: Nov 2020
22 citations
22 citations
119 days before retraction
No Effect of Metformin on Ovarian Cancer Survival: A Systematic Review and Meta-Analysis of Cohort Studies
Yongbo Wang, Xiaoxue Liu, Peng-Fei Yan et al. (6 authors)
Current Pharmaceutical Design
Published: Jul 2019
5 citations
5 citations
616 days before retraction
The unconventional role of Akt1 in the advanced cancers and in diabetes-promoted carcinogenesis
Abdulrahman Alwhaibi, Arti Verma, Mir S. Adil et al. (4 authors)
Pharmacological Research
Open Access
Published: May 2019
75 citations
75 citations
686 days before retraction
Quick Stats
Total Citations:
13
Years Since Retraction:
4.7 years
Open Access:
Yes
Last Checked:
Jul 24, 2025